Jefferies analyst Sheila Kahyaoglu downgrades Science Applications Intl (NYSE:SAIC) from Buy to Hold and announces $110 price target.
Alpine Immune Sciences To Present New Translational Data On Povetacicept And Acazicolcept In Systemic Lupus Erythematosus At American College Of Rheumatology Convergence 2023
Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, announced the Company will present new
